MedTrace Logo

Naproxen for Acute Pain After Surgery: A Randomized, Placebo-Controlled Trial

NCT00615875 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2008-02-14

No results posted yet for this study

Summary

The purpose of this study is to determine whether using an additional 48 hours of oral naproxen, after other post-operative pain medications have been stopped, will be effective in reducing opiate pain medication requirements and contribute to improved pain management.

Conditions

  • Pain, Postoperative

Interventions

DRUG

naproxen

opaque pale orange suspension: 20mL q12h x 4 doses mixed in juice.

DRUG

placebo

opaque pale orange suspension: 20mL q12h x 4 doses mixed in juice

Sponsors & Collaborators

  • Hamilton Health Sciences Corporation

    lead OTHER

Principal Investigators

  • Tuan Dinh, RPh · St. Joseph's Healthcare Hamilton

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-03-31
Primary Completion
2008-05-31
Completion
2008-06-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00615875 on ClinicalTrials.gov